Abhinav Shukla
Technik-/Wissenschafts-/F&E-Leiter bei SHATTUCK LABS, INC.
Vermögen: 586 171 $ am 31.05.2024
Aktive Positionen von Abhinav Shukla
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
SHATTUCK LABS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.06.2021 | - |
Karriereverlauf von Abhinav Shukla
Ehemalige bekannte Positionen von Abhinav Shukla
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Redpin Therapeutics, Inc.
Redpin Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Redpin Therapeutics, Inc. operates as a biotechnological platform which enables targeted regulation of neuronal activity in brain to achieve treatment and control of CNS circuit and other disorders. The company was founded by Elma S. Hawkins, Jeffrey Friedman, Scott Sternson Michael Kaplitt, Sarah Stanley and Jonathan Dordick in 2017 and is headquartered in New York, NY. | Technik-/Wissenschafts-/F&E-Leiter | 31.03.2020 | 01.06.2021 |
CRISPR THERAPEUTICS AG | Corporate Officer/Principal | 01.04.2019 | 01.11.2019 |
SHIRE | Corporate Officer/Principal | 01.04.2019 | 01.11.2019 |
KBI Biopharma, Inc.
KBI Biopharma, Inc. Miscellaneous Commercial ServicesCommercial Services KBI Biopharma, Inc. provides drug development and contract manufacturing services. It helps client partners accelerate and optimize drug development and manufacturing programs by offering an extensive suite of expert development and manufacturing services. The firm offers services to global pharmaceutical and biotechnology companies, and academic and non-profit organizations. The company was founded in 1996 and is headquartered in Durham, NC. | Corporate Officer/Principal | 01.11.2011 | 01.06.2018 |
AMGEN INC. | Corporate Officer/Principal | - | - |
BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | - | - |
Ausbildung von Abhinav Shukla
Rensselaer Polytechnic Institute | Doctorate Degree |
Indian Institute of Technology New Delhi | Graduate Degree |
Statistik
International
Vereinigte Staaten | 7 |
Indien | 2 |
Schweiz | 2 |
Operativ
Corporate Officer/Principal | 5 |
Chief Tech/Sci/R&D Officer | 2 |
Doctorate Degree | 1 |
Sektoral
Health Technology | 6 |
Commercial Services | 3 |
Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 4 |
---|---|
BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
AMGEN INC. | Health Technology |
SHATTUCK LABS, INC. | Health Technology |
CRISPR THERAPEUTICS AG | Health Technology |
Private Unternehmen | 3 |
---|---|
KBI Biopharma, Inc.
KBI Biopharma, Inc. Miscellaneous Commercial ServicesCommercial Services KBI Biopharma, Inc. provides drug development and contract manufacturing services. It helps client partners accelerate and optimize drug development and manufacturing programs by offering an extensive suite of expert development and manufacturing services. The firm offers services to global pharmaceutical and biotechnology companies, and academic and non-profit organizations. The company was founded in 1996 and is headquartered in Durham, NC. | Commercial Services |
Redpin Therapeutics, Inc.
Redpin Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Redpin Therapeutics, Inc. operates as a biotechnological platform which enables targeted regulation of neuronal activity in brain to achieve treatment and control of CNS circuit and other disorders. The company was founded by Elma S. Hawkins, Jeffrey Friedman, Scott Sternson Michael Kaplitt, Sarah Stanley and Jonathan Dordick in 2017 and is headquartered in New York, NY. | Commercial Services |
Shire Plc
Shire Plc Pharmaceuticals: MajorHealth Technology Shire Plc is a biopharmaceutical company, which engages in the research, development, licensing, manufacturing, marketing, distribution, and sale of medicines. Its products include adderall, advate, adynovate, agrylin, antithrombin 3, aralast, bebulin, buccolam, feiba, firazyr, and foznol. The company was founded in 1986 and is headquartered in Dublin, Ireland. | Health Technology |
- Börse
- Insiders
- Abhinav Shukla
- Erfahrung